Neuropeptide Y Promotes the Treatment of Adipose Stem Cells on Type 2 Diabetic Wounds
10.1007/s13770-023-00540-1
- Author:
Tinghuan LU
1
;
Lu CONG
;
Tong JIANG
;
Xiao DONG
;
Lili SONG
Author Information
1. College of Life Science, Qingdao Agricultural University, No. 700, Changcheng Road, Chengyang District, Qingdao 266109, Shandong, People’s Republic of China
- Publication Type:ORIGINAL ARTICLE
- From:
Tissue Engineering and Regenerative Medicine
2023;20(5):683-694
- CountryRepublic of Korea
- Language:English
-
Abstract:
BACKGROUND:Type 2 diabetes (T2D) is a common metabolic disorder. Due to insufficient insulin secretion or insulin resistance, increased blood glucose often leads to impaired wound healing in T2D patients. Our previous research showed that adipose-derived stem cells (ASCs) from normal mice and T2D mice improved the cutaneous wound healing of diabetic mice. We also found that the expression of neuropeptide Y (NPY) in T2D ASCs was significantly decreased.
METHODS:In order to explore the effects of NPY on ASCs and diabetic wound healing, we investigated the effects of NPY on ASCs proliferation and growth factors expression and secretion, the effects of NPY on skin fibroblasts, and the effects of NPY combined with ASCs on T2D wound healing.
RESULTS:The results showed that a certain concentration of NPY could promote the proliferation and the growth factors expression and secretion of ASCs, and promote the proliferation and migration of fibroblasts. At the same time, NPY and ASCs have a synergistic effect, which can promote wound healing and decrease inflammation in T2D wounds. NPY may regulate ASCs through the ERK pathway. These results are conducive to promoting ASCs and NPY in the treatment of diabetic wounds.
CONCLUSIONS:NPY can promote the effect of ASCs in the treatment of diabetic wounds.
